These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 25100136)

  • 41. IL28B polymorphisms predict response to therapy among chronic hepatitis C patients with HCV genotype 4.
    Antaki N; Bibert S; Kebbewar K; Asaad F; Baroudi O; Alideeb S; Hadad M; Abboud D; Sabah H; Bochud PY; Negro F
    J Viral Hepat; 2013 Jan; 20(1):59-64. PubMed ID: 23231085
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The predictive value of IL28B gene polymorphism for spontaneous clearance in a single source outbreak cohort is limited in patients carrying the CCR5Δ32 mutation.
    Nattermann J; Timm J; Nischalke HD; Olbrich A; Michalk M; Tillmann HL; Berg T; Wedemeyer H; Tenckhoff H; Wiese M; Kullig U; Göbel U; Capka E; Schiefke I; Güthof W; Grüngreiff K; König I; Roggendorf M; Sauerbruch T; Spengler U;
    J Hepatol; 2011 Dec; 55(6):1201-6. PubMed ID: 21703201
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Serum level of IP-10 increases predictive value of IL28B polymorphisms for spontaneous clearance of acute HCV infection.
    Beinhardt S; Aberle JH; Strasser M; Dulic-Lakovic E; Maieron A; Kreil A; Rutter K; Staettermayer AF; Datz C; Scherzer TM; Strassl R; Bischof M; Stauber R; Bodlaj G; Laferl H; Holzmann H; Steindl-Munda P; Ferenci P; Hofer H
    Gastroenterology; 2012 Jan; 142(1):78-85.e2. PubMed ID: 22192885
    [TBL] [Abstract][Full Text] [Related]  

  • 44. IL28B CC-genotype association with HLA-DQB1*0301 allele increases the prediction of spontaneous HCV RNA clearance in thalassaemic HCV-infected patients.
    Mangia A; Santoro R; Sarli R; Mottola L; Piazzolla V; Petruzzellis D; Bacca D; Clemente R; Copetti M; di Mauro L; Lotti G; Sacco M; Stefano I
    Antivir Ther; 2011; 16(8):1309-16. PubMed ID: 22155912
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Study of Interleukin 28B rs12979860 and rs8099917 Polymorphisms and T-helper 1 Response in Hepatitis C Virus Patients.
    Ea R; Aa G; Ag ES; Ma A
    Egypt J Immunol; 2015 Jun; 22(2):57-68. PubMed ID: 28502145
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Lack of Association Between Interleukin 28B Polymorphism and Vertical Transmission of Hepatitis C.
    Psaros Einberg A; Duberg AS; Filipovich O; Nyström J; Zhirkov A; Brenndörfer ED; Frelin L; Rukoiatkina E; Lobzin Y; Sällberg M; Fischler B; Lutckii A
    J Pediatr Gastroenterol Nutr; 2017 Dec; 65(6):608-612. PubMed ID: 28820758
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Differential distribution of IL28B.rs12979860 single-nucleotide polymorphism among Egyptian healthcare workers with and without a hepatitis C virus-specific cellular immune response.
    Abdelwahab SF; Zakaria Z; Sobhy M; Hamdy S; Mahmoud MA; Mikhail N; Allam WR; Rewisha E; Waked I
    Arch Virol; 2015 Jul; 160(7):1741-50. PubMed ID: 25971683
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Importance of IL28B gene polymorphisms in hepatitis C virus genotype 2 and 3 infected patients.
    Sarrazin C; Susser S; Doehring A; Lange CM; Müller T; Schlecker C; Herrmann E; Lötsch J; Berg T
    J Hepatol; 2011 Mar; 54(3):415-21. PubMed ID: 21112657
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Correlation of IL28B rs12979860 genotype and gender with spontaneous clearance of HCV infection: a Pakistani cross-section study.
    Ali Q; Jamal A; Imran M; Ullah S; Kalam I; Ullah S; Waqar AB
    Per Med; 2018 Nov; 15(6):495-502. PubMed ID: 30398404
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Meta-analysis: IL28B polymorphisms predict sustained viral response in HCV patients treated with pegylated interferon-α and ribavirin.
    Chen Y; Xu HX; Wang LJ; Liu XX; Mahato RI; Zhao YR
    Aliment Pharmacol Ther; 2012 Jul; 36(2):91-103. PubMed ID: 22591106
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Genetic variation in the interleukin-28B gene is associated with spontaneous clearance and progression of hepatitis C virus in Moroccan patients.
    Ezzikouri S; Alaoui R; Rebbani K; Brahim I; Fakhir FZ; Nadir S; Diepolder H; Khakoo SI; Thursz M; Benjelloun S
    PLoS One; 2013; 8(1):e54793. PubMed ID: 23358556
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Assessment of interleukin 28B genotype as a predictor of response to combined therapy with pegylated interferon plus ribavirin in HCV infected Egyptian patients.
    Fathy MM; Abo Taleb ME; El Hawary MS; Nabih MI; Aref WM; Makhlouf MM
    Cytokine; 2015 Aug; 74(2):268-72. PubMed ID: 26003758
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Association of a genetic polymorphism in ectonucleotide pyrophosphatase/phosphodiesterase 1 with hepatitis C virus infection and hepatitis C virus core antigen levels in subjects in a hyperendemic area of Japan.
    Takahama Y; Uto H; Kanmura S; Oketani M; Ido A; Kusumoto K; Hasuike S; Nagata K; Hayashi K; Stuver S; Okayama A; Tsubouchi H
    J Gastroenterol; 2008; 43(12):942-50. PubMed ID: 19107338
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Value of IL28B genotyping in patients with HCV-related mixed cryoglobulinemia: results of a large, prospective study.
    Piluso A; Giannini C; Fognani E; Gragnani L; Caini P; Monti M; Petrarca A; Ranieri J; Urraro T; Triboli E; Laffi G; Zignego AL
    J Viral Hepat; 2013 Apr; 20(4):e107-14. PubMed ID: 23490377
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Insulin resistance undermines the advantages of IL28B polymorphism in the pegylated interferon alpha-2b and ribavirin treatment of chronic hepatitis C patients with genotype 1.
    Ogawa E; Furusyo N; Murata M; Ikezaki H; Ihara T; Hayashi T; Toyoda K; Taniai H; Okada K; Kainuma M; Hayashi J
    J Hepatol; 2012 Sep; 57(3):534-40. PubMed ID: 22613000
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A single IL28B genotype SNP rs12979860 determination predicts treatment response in patients with chronic hepatitis C Genotype 1 virus.
    Halfon P; Bourliere M; Ouzan D; Maor Y; Renou C; Wartelle C; Pénaranda G; Tran A; Botta D; Oules V; Castellani P; Portal I; Argiro L; Dessein A
    Eur J Gastroenterol Hepatol; 2011 Oct; 23(10):931-5. PubMed ID: 21900787
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Impact of immunogenetic IL28B polymorphism on natural outcome of HCV infection.
    De Re V; Gragnani L; Fognani E; Piluso A; Izzo F; Mangia A; Crovatto M; Gava G; Casarin P; Sansonno D; Racanelli V; De Vita S; Pioltelli P; Caggiari L; De Zorzi M; Berretta M; Gini A; Zucchetto A; Buonaguro FM; De Paoli P; Zignego AL
    Biomed Res Int; 2014; 2014():710642. PubMed ID: 24707497
    [TBL] [Abstract][Full Text] [Related]  

  • 58. IL28B polymorphism associated with spontaneous clearance of hepatitis C infection in a Southern Brazilian HIV type 1 population.
    Lunge VR; da Rocha DB; Béria JU; Tietzmann DC; Stein AT; Simon D
    AIDS Res Hum Retroviruses; 2012 Feb; 28(2):215-9. PubMed ID: 21790472
    [TBL] [Abstract][Full Text] [Related]  

  • 59. BMI, male sex and IL28B genotype associated with persistently high hepatitis C virus RNA levels among chronically infected drug users up to 23 years following seroconversion.
    Grady BP; Prins M; Rebers S; Molenkamp R; Geskus RB; Schinkel J
    J Viral Hepat; 2015 Mar; 22(3):263-71. PubMed ID: 25174990
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A polymorphism near IL28B is associated with spontaneous clearance of acute hepatitis C virus and jaundice.
    Tillmann HL; Thompson AJ; Patel K; Wiese M; Tenckhoff H; Nischalke HD; Lokhnygina Y; Kullig U; Göbel U; Capka E; Wiegand J; Schiefke I; Güthoff W; Grüngreiff K; König I; Spengler U; McCarthy J; Shianna KV; Goldstein DB; McHutchison JG; Timm J; Nattermann J;
    Gastroenterology; 2010 Nov; 139(5):1586-92, 1592.e1. PubMed ID: 20637200
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.